1.
M SK, Katamreddy JD, P JR. A review on ANDA submission requirements for Generic drugs: “Paragraph IV certification” as per FDA CDER guidelines. Int J Drug Reg Affairs [Internet]. 2018Sep.15 [cited 2020Jul.5];6(3):5-12. Available from: https://ijdra.com/index.php/journal/article/view/260